|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61K 47/54 | |||
| C07K 14/50 | |||
| A61K 38/18 |
| (11) | Number of the document | 3236991 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15817847.5 |
| Date of filing the European patent application | 2015-12-22 | |
| (97) | Date of publication of the European application | 2017-11-01 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/080969 |
| Date | 2015-12-22 |
| (87) | Number | WO 2016/102562 |
| Date | 2016-06-30 |
| (30) | Number | Date | Country code |
| 14199935 | 2014-12-23 | EP |
| (72) |
WIECZOREK, Birgit, DK
TAGMOSE, Tina M ller, DK
SASS- RUM, Kristian, DK
ANDERSEN, Birgitte, DK
OLSEN, J rgen, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | FGF21 DERIVATIVES AND USES THEREOF |
| FGF21 DERIVATIVES AND USES THEREOF |